Albeit those results were encouraging, being obtained in orthotopic tumors that faithfully mimic the growth pattern of the clinical tumors, the survival improvements were lower than those observed in previous studies performed on orthotopic tumors driven by the established U87 and U1242 glioma cell lines bearing specific TP53 mutations. The gene discussed is TP53; the disease is glioma.